Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,603 | 164 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $417.54 | 33 | $0 (2024) |
| Amgen Inc. | $390.28 | 22 | $0 (2024) |
| ABBVIE INC. | $386.29 | 24 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $172.05 | 12 | $0 (2022) |
| Daiichi Sankyo Inc. | $120.07 | 8 | $0 (2022) |
| SANOFI PASTEUR INC. | $110.67 | 6 | $0 (2023) |
| Apellis Pharmaceuticals, Inc. | $110.55 | 1 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $110.16 | 6 | $0 (2021) |
| Flexion Therapeutics, Inc. | $84.62 | 3 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $77.55 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $163.55 | 10 | Novo Nordisk Inc ($68.38) |
| 2023 | $496.51 | 26 | AbbVie Inc. ($286.81) |
| 2022 | $554.34 | 36 | Biohaven Pharmaceutical Holding Company Ltd. ($172.05) |
| 2021 | $446.97 | 25 | Biohaven Pharmaceuticals, Inc. ($96.40) |
| 2020 | $300.20 | 26 | Novo Nordisk Inc ($116.87) |
| 2019 | $222.23 | 15 | Amgen Inc. ($84.45) |
| 2018 | $315.92 | 18 | Flexion Therapeutics, Inc. ($69.00) |
| 2017 | $103.36 | 8 | Lilly USA, LLC ($39.82) |
All Payment Transactions
164 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Bone Health | ||||||
| 10/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: PAIN | ||||||
| 06/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Diabetes | ||||||
| 03/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: PAIN | ||||||
| 01/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Bone Health | ||||||
| 09/14/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2023 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Vaccines | ||||||
| 08/28/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: PAIN | ||||||
| 06/05/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $110.55 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,571 | 1,737 | $301,421 | $93,897 |
| 2022 | 15 | 1,590 | 1,797 | $313,820 | $99,954 |
| 2021 | 13 | 1,518 | 1,696 | $299,670 | $97,527 |
| 2020 | 13 | 1,449 | 1,619 | $276,666 | $85,569 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 428 | 454 | $101,242 | $32,090 | 31.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 363 | 389 | $59,517 | $20,804 | 35.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 119 | 119 | $31,892 | $10,315 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 123 | $16,236 | $6,901 | 42.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 126 | 174 | $13,746 | $6,221 | 45.3% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 19 | 19 | $18,000 | $4,238 | 23.5% |
| 92134 | Imaging of retina | Office | 2023 | 144 | 152 | $13,528 | $3,933 | 29.1% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2023 | 28 | 43 | $18,060 | $2,621 | 14.5% |
| 92133 | Imaging of optic nerve | Office | 2023 | 109 | 116 | $10,092 | $2,389 | 23.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 62 | 64 | $10,368 | $2,301 | 22.2% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 30 | 30 | $4,350 | $1,349 | 31.0% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 34 | 35 | $2,870 | $588.53 | 20.5% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 18 | 19 | $1,520 | $147.39 | 9.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 396 | 436 | $97,228 | $32,070 | 33.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 380 | 404 | $61,812 | $21,792 | 35.3% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 118 | 118 | $31,624 | $9,836 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 91 | 145 | $19,140 | $8,901 | 46.5% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 26 | 28 | $25,200 | $6,473 | 25.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 121 | 161 | $12,719 | $5,609 | 44.1% |
| 92134 | Imaging of retina | Office | 2022 | 129 | 147 | $13,083 | $3,813 | 29.1% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 72 | 78 | $12,636 | $2,946 | 23.3% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2022 | 26 | 38 | $15,960 | $2,492 | 15.6% |
| 92133 | Imaging of optic nerve | Office | 2022 | 109 | 115 | $10,005 | $2,452 | 24.5% |
| 92002 | New patient problem focused exam of visual system | Office | 2022 | 39 | 39 | $5,655 | $1,682 | 29.7% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 40 | 45 | $3,690 | $769.68 | 20.9% |
About Dr. William Beck, MD
Dr. William Beck, MD is a Ophthalmology healthcare provider based in Newton, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104894070.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Beck, MD has received a total of $2,603 in payments from pharmaceutical and medical device companies, with $163.55 received in 2024. These payments were reported across 164 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,603).
As a Medicare-enrolled provider, Beck has provided services to 6,128 Medicare beneficiaries, totaling 6,849 services with total Medicare billing of $376,946. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Newton, KS
- Active Since 03/08/2006
- Last Updated 03/07/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1104894070
Products in Payments
- NURTEC ODT (Drug) $340.38
- Ozempic (Drug) $236.30
- Aimovig (Biological) $228.11
- QULIPTA (Drug) $211.14
- UBRELVY (Drug) $175.15
- INJECTAFER (Drug) $120.07
- Syfovre (Drug) $110.55
- EVENITY (Biological) $91.88
- Zilretta (Drug) $84.62
- XARELTO (Drug) $77.55
- Rybelsus (Drug) $72.17
- VYVANSE (Drug) $52.31
- Vascepa (Drug) $51.90
- JARDIANCE (Drug) $47.60
- Prolia (Biological) $47.54
- PENTACEL (Drug) $44.62
- PRALUENT ALIROCUMAB INJECTION (Biological) $39.73
- TRULICITY (Drug) $36.51
- MENACTRA (Drug) $33.67
- RYBELSUS (Drug) $33.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Newton
Marc Leibole, M.d, M.D
Ophthalmology — Payments: $9,972
Jill Smith, Md, MD
Ophthalmology — Payments: $1,664
Amit Vora
Ophthalmology — Payments: $1,192
Laura Hirschfeld, Md, MD
Ophthalmology — Payments: $815.80
Dr. Jill Carmody, M.d, M.D
Ophthalmology — Payments: $609.17
Dr. Miriam Dougherty, M.d, M.D
Ophthalmology — Payments: $516.88